As of Sep 23
| -0.13 / -4.55%|
The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +119.78% increase from the last price of 2.73.
The current consensus among 2 polled investment analysts is to Buy stock in Pain Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.